Showing results (121-130 of 295) with videos related to

Sort By:
Pageof 30
Scientific Reports|November 9, 2022
Genomic analysis of early-stage lung cancer reveals a role for TP53 mutations in distant metastasisDebra Van Egeren, Khushi Kohli, Jeremy L Warner, et al.
The Oncologist|August 2, 2023
A Phase I Dose-Escalation Study of LY3405105, a Covalent Inhibitor of Cyclin-Dependent Kinase 7, Administered to Patients With Advanced Solid TumorsElena Garralda, Alison M Schram, Philippe L Bedard, et al.
British Journal of Cancer|August 25, 2022
Evaluation of the patient experience of symptomatic adverse events on Phase I clinical trials using PRO-CTCAEGeoffrey A Watson, Zachary W Veitch, Daniel Shepshelovich, et al.
Investigational New Drugs|September 13, 2014
A phase I trial of pantoprazole in combination with doxorubicin in patients with advanced solid tumors: evaluation of pharmacokinetics of both drugs and tissue penetration of doxorubicinIrene Brana, Alberto Ocana, Eric X Chen, et al.
Journal of the National Cancer Institute|November 26, 2013
Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysisFrancisco E Vera-Badillo, Arnoud J Templeton, Paulo de Gouveia, et al.
The American Journal of Cardiology|September 19, 2016
A Matched Cohort Study of Patients With End-Stage Heart Failure from Anthracycline-Induced Cardiomyopathy Requiring Advanced Cardiac SupportGarry R Thomas, Michael A McDonald, Jennifer Day, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|October 10, 2012
Sputum microRNA profiling: a novel approach for the early detection of non-small cell lung cancerWilson H Roa, Julian O Kim, Rene Razzak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2022
Safety, pharmacokinetics, and antitumor activity of the anti-CEACAM5-DM4 antibody-drug conjugate tusamitamab ravtansine (SAR408701) in patients with advanced solid tumors: first-in-human dose-escalation studyA Gazzah, P L Bedard, C Hierro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2016
Conditional Survival of Patients With Metastatic Testicular Germ Cell Tumors Treated With First-Line Curative TherapyJenny J Ko, Brandon Bernard, Ben Tran, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Biased signaling at NTSR1 differentially regulates inhibitory synaptic transmission in the extended amygdala and suppresses motivated feeding in miceSarah E Sizer, Alex R Brown, Josephine K Anderson, et al.
Pageof 30